Alliancebernstein L.P. Voyager Therapeutics, Inc. Put Options Transaction History
Alliancebernstein L.P.
- $290 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VYGR
# of Institutions
118Shares Held
32.6MCall Options Held
32.9KPut Options Held
22.7K-
Black Rock Inc. New York, NY5.31MShares$24.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.8MShares$22.4 Million0.26% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$18.3 Million1.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$15 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY1.48MShares$6.89 Million0.24% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $180M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...